Olive Leaf Extract
Polyphenol-rich leaf extract that modestly lowers blood pressure.
What is Olive Leaf Extract?
Olive Leaf Extract (Olea europaea) is a heart and metabolic supplement used for lower blood pressure. NutriDex grades the human evidence as Moderate. Olive leaf extract is a polyphenol-rich preparation from Olea europaea, standardized to oleuropein. The best evidence is for blood pressure: a 2022 meta-analysis of 12 trials (819 people) found systolic pressure fell about 3.9 mmHg overall and roughly 4.8 mmHg in hypertensive subgroups, with a small triglyceride drop. A 2025 multicenter RCT in 621 hypertensive adults reported a 24-hour systolic reduction of ~6.4 mmHg from baseline (1.5 mmHg vs placebo). Metabolic effects are less consistent: a small diabetes RCT and a crossover trial showed lower HbA1c and ~15% better insulin sensitivity, but the meta-analysis found no glucose benefit and a 2025 pilot trial in type-2 diabetes was null for HbA1c. Trials are mostly short (6–12 weeks), small, and use varied formulations, so the effect is likely genuine but modest and best viewed as adjunctive rather than a replacement for medication.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Lower blood pressure12-RCT meta-analysis shows ~3.9 mmHg systolic drop (more in hypertensives); trials short and formulations vary, so adjunctive at best. | Moderate | ↑ benefit · small | 3 |
| Lower triglyceridesSame meta-analysis found only ~9.5 mg/dL triglyceride drop; an 8-week RCT found no lipid change, so the signal is weak. | Preliminary | ↑ benefit · small | 1 |
| Improve glycemic control / insulin sensitivityTwo small RCTs showed lower HbA1c and ~15% better insulin sensitivity, but the meta-analysis and a 2025 pilot were null. | Mixed | ↔ mixed | 4 |